Table 2.
Control period | COVID-19 period | p value | |
---|---|---|---|
IVT-only group (n = 71) | n = 42 | n = 29 | |
Onset-to-door time, min | 71 [61–102] | 89 [58–106] | 0.61 |
Door-to-imaging time, min | 23 [13–52] | 16 [14–34] | 0.63 |
Door-to-needle time, min | 53 [42–95] | 54 [43–69] | 0.77 |
MT ± IVT group (n = 137) | n = 65 | nn = 72 | |
Onset-to-door time, min | 84 [59–118] | 91 [60–139] | 0.34 |
Door-to-imaging time, min | 21 [16–38] | 25 [16–54] | 0.30 |
Door-to-needle time, min | 55 [44–80] | 60 [46–80] | 0.88 |
Door-to-groin puncture time, min | 121 [80–210] | 185 [103–270] | 0.01 |
Direct admission to Lyon CSC | 84 [67–94] | 81 [65–111] | 0.68 |
Transfer from PCS or ED | 210 [163–260] | 237 [187–339] | 0.04 |
Significant results appear in bold
IVT intravenous thrombolysis, MT mechanical thrombectomy, CSC comprehensive stroke center, PCS primary stroke center, ED emergency department